CLINICAL TRIALS PROFILE FOR MD-GASTROVIEW

All Clinical Trials for MD-GASTROVIEW

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00478556 ↗	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	GE Healthcare	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT00478556 ↗	Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT	Completed	University of Alabama at Birmingham	Phase 4	2007-08-01	Patients who are scheduled by their health care provider for routine computed tomography (CT) scan will be asked to participate in this study. The primary purpose is to determine if there is a difference in patient preference for Omnipaque versus Gastroview as oral contrast for abdominal pelvic CT. A secondary objective is to evaluate if there is significant difference in bowel opacification for the two agents.
NCT01790139 ↗	Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles	Completed	GE Healthcare	N/A	2013-02-01	To determine whether colonic bubbles associated with CT colonography performed with iohexol for fecal/fluid tagging could be reduced by adding simethicone to the standard cathartic preparation.
NCT01790139 ↗	Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles	Completed	Asan Medical Center	N/A	2013-02-01	To determine whether colonic bubbles associated with CT colonography performed with iohexol for fecal/fluid tagging could be reduced by adding simethicone to the standard cathartic preparation.
NCT02928458 ↗	Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol	Withdrawn	The Guthrie Clinic	N/A	2015-09-01	This research study is for patients with adhesive small bowel obstruction (ASBO). ASBO is a condition in which the small intestine gets blocked due to scars called adhesions. To see the blockage, a contrast agent is given and an x-ray is taken of the belly (abdomen). MD Gastroview and omnipaque are two contrast agents that may be given as part of your normal care for ASBO. This study hopes to see if one is better than the other.

Clinical Trial Conditions for MD-GASTROVIEW

Condition Name

Condition Name for MD-GASTROVIEW
Intervention	Trials
Colorectal Neoplasms	1
Healthy	1
Intestinal Obstruction	1

Condition MeSH

Condition MeSH for MD-GASTROVIEW
Intervention	Trials
Intestinal Obstruction	1
Colorectal Neoplasms	1

Clinical Trial Locations for MD-GASTROVIEW

Trials by Country

Trials by Country for MD-GASTROVIEW
Location	Trials
United States	2
Korea, Republic of	1

Trials by US State

Trials by US State for MD-GASTROVIEW
Location	Trials
Pennsylvania	1
Alabama	1

Clinical Trial Progress for MD-GASTROVIEW

Clinical Trial Phase

Clinical Trial Phase for MD-GASTROVIEW
Clinical Trial Phase	Trials
Phase 4	1
N/A	2

Clinical Trial Status

Clinical Trial Status for MD-GASTROVIEW
Clinical Trial Phase	Trials
Completed	2
Withdrawn	1

Clinical Trial Sponsors for MD-GASTROVIEW

Sponsor Name

Sponsor Name for MD-GASTROVIEW
Sponsor	Trials
GE Healthcare	2
University of Alabama at Birmingham	1
Asan Medical Center	1

Sponsor Type

Sponsor Type for MD-GASTROVIEW
Sponsor	Trials
Other	3
Industry	2